Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount

Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount

Submitted by admin on November 9, 2018 - 12:03pm
Source: 
Reuters
News Tags: 
Coherus Biosciences
Amgen
biosimilars
Neulasta
Headline: 
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
snippet: 

Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc’s infection-fighting treatment, Neulasta, at a 33 percent discount.

Do Not Allow Advertisers to Use My Personal information